B Williams-Jones. Somatic Cell Therapy: A Genetic Rescue for a Tattered Immune System? Bioétique online [6]Arquivado 19 de maio de 2014 en Wayback Machine.
"International Law". The Genetics and Public Policy Center, Johns Hopkins University Berman Institute of Bioethics. 2010. Arquivado dende o orixinal o 02 de setembro de 2014. Consultado o 08 de xuño de 2015.
Cepko CL; Roberts BE; Mulligan RC (1984). "Construction and applications of a highly transmissible murine retrovirus shuttle vector". Cell37 (3): 1053–62. PMID6331674. doi:10.1016/0092-8674(84)90440-9.
Trojan J., Johnson T., Rudin S., Ilan Ju., Tykocinski M., Ilan J. (1993). "Treatment and prevention of rat glioblastoma by immugenic C6 cells expressing antisense insulin-like growth factor I RNA". Science259: 94–97. doi:10.1126/science.8418502.
Trojan A, Jay LM, Kasprzak H, Anthony DD, Trojan J (2014). "Immunotherapy of malignant tumors using antisense anti-IGF-I approach: case of glioblastoma". Journal of Cancer Therapy5: 685–705. doi:10.4236/jct.2014.57078.
Lee, Tim WR; Southern, K. W. (26 November 2013). "Topical cystic fibrosis transmembrane conductance regulator gene replacement for cystic fibrosis-related lung disease". Cochrane Database Syst Rev.11 (11): CD005599. PMID24282073. doi:10.1002/14651858.CD005599.pub4.
Olowoyeye, A; Okwundu, C. I. (October 2015). "Gene therapy for sickle cell disease". Cochrane Database of Systematic Reviews11 (10): CD007652. PMID23152248. doi:10.1002/14651858.CD007652.pub3.
Baltimore, David; Berg, Paul; Botchan, Dana; Charo, R. Alta; Church, George; Corn, Jacob E.; Daley, George Q.; Doudna, Jennifer A.; Fenner, Marsha; Greely, Henry T.; Jinek, Martin; Martin, G. Steven; Penhoet, Edward; Puck, Jennifer; Sternberg, Samuel H.; Weissman, Jonathan S.; Yamamoto, Keith R. (19 March 2015). "A prudent path forward for genomic engineering and germline gene modification". Science. doi:10.1126/science.aab1028. Consultado o 20 March 2015.
Roco MC; Bainbridge WS (2002). "Converging Technologies for Improving Human Performance: Integrating From the Nanoscale". Journal of Nanoparticle Research4 (4): 281–295. doi:10.1023/A:1021152023349.
Pezzoli, D.; Chiesa, R.; De Nardo, L.; Candiani, G. (2012). " We still have a long way to go to effectively deliver genes!". Journal of Applied Biomaterials & Functional Materials 2 (10): 82. doi:10.5301/JABFM.2012.9707. [1]Arquivado 20 de xuño de 2015 en Wayback Machine.
Allhoff, F. (2005). "Germ-Line Genetic Enhancement and Rawlsian Primary Goods". Kennedy Institute of Ethics Journal 15: 39. doi:10.1353/ken.2005.0007. [11]Arquivado 21 de xuño de 2015 en Wayback Machine.
lifesciencesfoundation.org
"The first gene therapy". Life Sciences Foundation. 21 June 2011. Arquivado dende o orixinal o 28 de novembro de 2012. Consultado o 7 January 2014.
Cavazzana-Calvo, M.; Thrasher, A.; Mavilio, F. (2004). "The future of gene therapy". Nature 427 (6977): 779. doi:10.1038/427779a. [5]
Gardner, M. R.; Kattenhorn, L. M.; Kondur, H. R.; von Schaewen, M.; Dorfman, T.; Chiang, J. J.; Haworth, K. G.; Decker, J. M.; Alpert, M. D.; Bailey, C. C.; Neale, E. S.; Fellinger, C. H.; Joshi, V. R.; Fuchs, S. P.; Martinez-Navio, J. M.; Quinlan, B. D.; Yao, A. Y.; Mouquet, H.; Gorman, J.; Zhang, B.; Poignard, P.; Nussenzweig, M. C.; Burton, D. R.; Kwong, P. D.; Piatak, M.; Lifson, J. D.; Gao, G.; Desrosiers, R. C.; Evans, D. T. et al. (2015). "AAV-expressed eCD4-Ig provides durable protection from multiple SHIV challenges". Nature 519 (7541): 87. doi:10.1038/nature14264. [8]
Maguire, A. M.; Simonelli, F.; Pierce, E. A.; Pugh Jr, E. N.; Mingozzi, F.; Bennicelli, J.; Banfi, S.; Marshall, K. A.; Testa, F.; Surace, E. M.; Rossi, S.; Lyubarsky, A.; Arruda, V. R.; Konkle, B.; Stone, E.; Sun, J.; Jacobs, J.; Dell'Osso, L.; Hertle, R.; Ma, J. X.; Redmond, T. M.; Zhu, X.; Hauck, B.; Zelenaia, O.; Shindler, K. S.; Maguire, M. G.; Wright, J. F.; Volpe, N. J.; McDonnell, J. W.; Auricchio, A. (2008). "Safety and Efficacy of Gene Transfer for Leber's Congenital Amaurosis". New England Journal of Medicine 358 (21): 2240–2248. doi:10.1056/NEJMoa0802315. PMC 2829748. PMID 18441370.
Simonelli, F.; Maguire, A. M.; Testa, F.; Pierce, E. A.; Mingozzi, F.; Bennicelli, J. L.; Rossi, S.; Marshall, K.; Banfi, S.; Surace, E. M.; Sun, J.; Redmond, T. M.; Zhu, X.; Shindler, K. S.; Ying, G. S.; Ziviello, C.; Acerra, C.; Wright, J. F.; McDonnell, J. W.; High, K. A.; Bennett, J.; Auricchio, A. (2009). "Gene Therapy for Leber's Congenital Amaurosis is Safe and Effective Through 1.5 Years After Vector Administration". Molecular Therapy 18 (3): 643–650. doi:10.1038/mt.2009.277. PMC 2839440. PMID 19953081.
Cideciyan, A. V.; Hauswirth, W. W.; Aleman, T. S.; Kaushal, S.; Schwartz, S. B.; Boye, S. L.; Windsor, E. A. M.; Conlon, T. J.; Sumaroka, A.; Roman, A. J.; Byrne, B. J.; Jacobson, S. G. (2009). "Vision 1 Year after Gene Therapy for Leber's Congenital Amaurosis". New England Journal of Medicine 361 (7): 725–727. doi:10.1056/NEJMc0903652. PMC 2847775. PMID 19675341.
Bainbridge, J. W. B.; Smith, A. J.; Barker, S. S.; Robbie, S.; Henderson, R.; Balaggan, K.; Viswanathan, A.; Holder, G. E.; Stockman, A.; Tyler, N.; Petersen-Jones, S.; Bhattacharya, S. S.; Thrasher, A. J.; Fitzke, F. W.; Carter, B. J.; Rubin, G. S.; Moore, A. T.; Ali, R. R. (2008). "Effect of Gene Therapy on Visual Function in Leber's Congenital Amaurosis". New England Journal of Medicine 358 (21): 2231–2239. doi:10.1056/NEJMoa0802268. PMID 18441371.
Fischer, A.; Hacein-Bey-Abina, S.; Cavazzana-Calvo, M. (2010). "20 years of gene therapy for SCID". Nature Immunology 11 (6): 457–460. doi:10.1038/ni0610-457. PMID 20485269.
Ferrua, F.; Brigida, I.; Aiuti, A. (2010). "Update on gene therapy for adenosine deaminase-deficient severe combined immunodeficiency". Current Opinion in Allergy and Clinical Immunology 10 (6): 551–556. doi:10.1097/ACI.0b013e32833fea85. PMID 20966749.
Cartier N; Aubourg P (2009). "Hematopoietic Stem Cell Transplantation and Hematopoietic Stem Cell Gene Therapy in X-Linked Adrenoleukodystrophy". Brain Pathology20 (4): 857–862. PMID20626747. doi:10.1111/j.1750-3639.2010.00394.x.
Lewitt, P. A.; Rezai, A. R.; Leehey, M. A.; Ojemann, S. G.; Flaherty, A. W.; Eskandar, E. N.; Kostyk, S. K.; Thomas, K.; Sarkar, A.; Siddiqui, M. S.; Tatter, S. B.; Schwalb, J. M.; Poston, K. L.; Henderson, J. M.; Kurlan, R. M.; Richard, I. H.; Van Meter, L.; Sapan, C. V.; During, M. J.; Kaplitt, M. G.; Feigin, A. (2011). "AAV2-GAD gene therapy for advanced Parkinson's disease: A double-blind, sham-surgery controlled, randomised trial". The Lancet Neurology 10 (4): 309–319. doi:10.1016/S1474-4422(11)70039-4. PMID 21419704.
Vannucci, L; Lai, M; Chiuppesi, F; Ceccherini-Nelli, L; Pistello, M (2013). "Viral vectors: A look back and ahead on gene transfer technology". The new microbiologica 36 (1): 1–22. PMID 23435812.
Woods, N. B.; Bottero, V.; Schmidt, M.; Von Kalle, C.; Verma, I. M. (2006). "Gene therapy: Therapeutic gene causing lymphoma". Nature 440 (7088): 1123. doi:10.1038/4401123a. PMID 16641981.
Thrasher, A. J.; Gaspar, H. B.; Baum, C.; Modlich, U.; Schambach, A.; Candotti, F.; Otsu, M.; Sorrentino, B.; Scobie, L.; Cameron, E.; Blyth, K.; Neil, J.; Abina, S. H. B.; Cavazzana-Calvo, M.; Fischer, A. (2006). "Gene therapy: X-SCID transgene leukaemogenicity". Nature 443 (7109): E5–E6; discussion E6–7. doi:10.1038/nature05219. PMID 16988659.
Frank, K. M.; Hogarth, D. K.; Miller, J. L.; Mandal, S.; Mease, P. J.; Samulski, R. J.; Weisgerber, G. A.; Hart, J. (2009). "Investigation of the Cause of Death in a Gene-Therapy Trial". New England Journal of Medicine 361 (2): 161–169. doi:10.1056/NEJMoa0801066. PMID 19587341.
Ott, M. G.; Schmidt, M.; Schwarzwaelder, K.; Stein, S.; Siler, U.; Koehl, U.; Glimm, H.; Kühlcke, K.; Schilz, A.; Kunkel, H.; Naundorf, S.; Brinkmann, A.; Deichmann, A.; Fischer, M.; Ball, C.; Pilz, I.; Dunbar, C.; Du, Y.; Jenkins, N. A.; Copeland, N. G.; Lüthi, U.; Hassan, M.; Thrasher, A. J.; Hoelzer, D.; Von Kalle, C.; Seger, R.; Grez, M. (2006). "Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1". Nature Medicine 12 (4): 401–409. doi:10.1038/nm1393. PMID 16582916.
Brown, B. D.; Venneri, M. A.; Zingale, A.; Sergi, L. S.; Naldini, L. (2006). "Endogenous microRNA regulation suppresses transgene expression in hematopoietic lineages and enables stable gene transfer". Nature Medicine 12 (5): 585–591. doi:10.1038/nm1398. PMID 16633348.
Morgan, R. A.; Dudley, M. E.; Wunderlich, J. R.; Hughes, M. S.; Yang, J. C.; Sherry, R. M.; Royal, R. E.; Topalian, S. L.; Kammula, U. S.; Restifo, N. P.; Zheng, Z.; Nahvi, A.; De Vries, C. R.; Rogers-Freezer, L. J.; Mavroukakis, S. A.; Rosenberg, S. A. (2006). "Cancer Regression in Patients After Transfer of Genetically Engineered Lymphocytes". Science 314 (5796): 126–129. doi:10.1126/science.1129003. PMC 2267026. PMID 16946036.
Levine, B. L.; Humeau, L. M.; Boyer, J.; MacGregor, R. -R.; Rebello, T.; Lu, X.; Binder, G. K.; Slepushkin, V.; Lemiale, F.; Mascola, J. R.; Bushman, F. D.; Dropulic, B.; June, C. H. (2006). "Gene transfer in humans using a conditionally replicating lentiviral vector". Proceedings of the National Academy of Sciences 103 (46): 17372–17377. doi:10.1073/pnas.0608138103. PMC 1635018. PMID 17090675.
Komáromy, A.; Alexander, J.; Rowlan, J.; Garcia, M.; Chiodo, V.; Kaya, A.; Tanaka, J.; Acland, G.; Hauswirth, W.; Aguirre, G. D. (2010). "Gene therapy rescues cone function in congenital achromatopsia". Human Molecular Genetics 19 (13): 2581–2593. doi:10.1093/hmg/ddq136. PMC 2883338. PMID 20378608.
Cavazzana-Calvo, M.; Payen, E.; Negre, O.; Wang, G.; Hehir, K.; Fusil, F.; Down, J.; Denaro, M.; Brady, T.; Westerman, K.; Cavallesco, R.; Gillet-Legrand, B.; Caccavelli, L.; Sgarra, R.; Maouche-Chrétien, L.; Bernaudin, F. O.; Girot, R.; Dorazio, R.; Mulder, G. J.; Polack, A.; Bank, A.; Soulier, J.; Larghero, J. R. M.; Kabbara, N.; Dalle, B.; Gourmel, B.; Socie, G. R.; Chrétien, S.; Cartier, N.; Aubourg, P. (2010). "Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia". Nature 467 (7313): 318–22. doi:10.1038/nature09328. PMC 3355472. PMID 20844535.
Galanello, R.; Origa, R. (2010). "Beta-thalassemia". Orphanet Journal of Rare Diseases 5: 11. doi:10.1186/1750-1172-5-11. PMC 2893117. PMID 20492708.
Yang, Z. J.; Zhang, Y. R.; Chen, B.; Zhang, S. L.; Jia, E. Z.; Wang, L. S.; Zhu, T. B.; Li, C. J.; Wang, H.; Huang, J.; Cao, K. J.; Ma, W. Z.; Wu, B.; Wang, L. S.; Wu, C. T. (2008). "Phase I clinical trial on intracoronary administration of Ad-hHGF treating severe coronary artery disease". Molecular Biology Reports 36 (6): 1323–1329. doi:10.1007/s11033-008-9315-3. PMID 18649012.
Hahn, W.; Pyun, W. B.; Kim, D. S.; Yoo, W. S.; Lee, S. D.; Won, J. H.; Shin, G. J.; Kim, J. M.; Kim, S. (2011). "Enhanced cardioprotective effects by coexpression of two isoforms of hepatocyte growth factor from naked plasmid DNA in a rat ischemic heart disease model". The Journal of Gene Medicine 13 (10): 549–555. doi:10.1002/jgm.1603. PMID 21898720.
Biffi, A.; Montini, E.; Lorioli, L.; Cesani, M.; Fumagalli, F.; Plati, T.; Baldoli, C.; Martino, S.; Calabria, A.; Canale, S.; Benedicenti, F.; Vallanti, G.; Biasco, L.; Leo, S.; Kabbara, N.; Zanetti, G.; Rizzo, W. B.; Mehta, N. A. L.; Cicalese, M. P.; Casiraghi, M.; Boelens, J. J.; Del Carro, U.; Dow, D. J.; Schmidt, M.; Assanelli, A.; Neduva, V.; Di Serio, C.; Stupka, E.; Gardner, J.; Von Kalle, C. (2013). "Lentiviral Hematopoietic Stem Cell Gene Therapy Benefits Metachromatic Leukodystrophy". Science 341 (6148): 1233158. doi:10.1126/science.1233158. PMID 23845948.
Aiuti, A.; Biasco, L.; Scaramuzza, S.; Ferrua, F.; Cicalese, M. P.; Baricordi, C.; Dionisio, F.; Calabria, A.; Giannelli, S.; Castiello, M. C.; Bosticardo, M.; Evangelio, C.; Assanelli, A.; Casiraghi, M.; Di Nunzio, S.; Callegaro, L.; Benati, C.; Rizzardi, P.; Pellin, D.; Di Serio, C.; Schmidt, M.; Von Kalle, C.; Gardner, J.; Mehta, N.; Neduva, V.; Dow, D. J.; Galy, A.; Miniero, R.; Finocchi, A.; Metin, A. (2013). "Lentiviral Hematopoietic Stem Cell Gene Therapy in Patients with Wiskott-Aldrich Syndrome". Science 341 (6148): 1233151. doi:10.1126/science.1233151. PMID 23845947.
Lee, Tim WR; Southern, K. W. (26 November 2013). "Topical cystic fibrosis transmembrane conductance regulator gene replacement for cystic fibrosis-related lung disease". Cochrane Database Syst Rev.11 (11): CD005599. PMID24282073. doi:10.1002/14651858.CD005599.pub4.
MacLaren, R. E.; Groppe, M.; Barnard, A. R.; Cottriall, C. L.; Tolmachova, T.; Seymour, L.; Clark, K. R.; During, M. J.; Cremers, F. P. M.; Black, G. C. M.; Lotery, A. J.; Downes, S. M.; Webster, A. R.; Seabra, M. C. (2014). "Retinal gene therapy in patients with choroideremia: Initial findings from a phase 1/2 clinical trial". The Lancet 383 (9923): 1129–37. doi:10.1016/S0140-6736(13)62117-0. PMID 24439297.
Tebas, P.; Stein, D.; Tang, W. W.; Frank, I.; Wang, S. Q.; Lee, G.; Spratt, S. K.; Surosky, R. T.; Giedlin, M. A.; Nichol, G.; Holmes, M. C.; Gregory, P. D.; Ando, D. G.; Kalos, M.; Collman, R. G.; Binder-Scholl, G.; Plesa, G.; Hwang, W. T.; Levine, B. L.; June, C. H. (2014). "Gene Editing ofCCR5in Autologous CD4 T Cells of Persons Infected with HIV". New England Journal of Medicine 370 (10): 901–10. doi:10.1056/NEJMoa1300662. PMID 24597865.
Olowoyeye, A; Okwundu, C. I. (October 2015). "Gene therapy for sickle cell disease". Cochrane Database of Systematic Reviews11 (10): CD007652. PMID23152248. doi:10.1002/14651858.CD007652.pub3.
Kayser, B.; Mauron, A.; Miah, A. (2007). "Current anti-doping policy: A critical appraisal". BMC Medical Ethics 8: 2. doi:10.1186/1472-6939-8-2. PMC 1851967. PMID 17394662.
Smith KR, Chan S, Harris J. Human germline genetic modification: scientific and bioethical perspectives. Arch Med Res. 2012 Oct;43(7):491-513. doi: 10.1016/j.arcmed.2012.09.003. PMID 23072719
Powell, R.; Buchanan, A. (2011). "Breaking Evolution's Chains: The Prospect of Deliberate Genetic Modification in Humans". Journal of Medicine and Philosophy 36: 6. doi:10.1093/jmp/jhq057. [9]
Blaese, R. M.; Culver, K. W.; Miller, A. D.; Carter, C. S.; Fleisher, T.; Clerici, M.; Shearer, G.; Chang, L.; Chiang, Y.; Tolstoshev, P.; Greenblatt, J. J.; Rosenberg, S. A.; Klein, H.; Berger, M.; Mullen, C. A.; Ramsey, W. J.; Muul, L.; Morgan, R. A.; Anderson, W. F. (1995). "T Lymphocyte-Directed Gene Therapy for ADA- SCID: Initial Trial Results After 4 Years". Science 270 (5235): 475. doi:10.1126/science.270.5235.475. [4]
Cartier, N.; Hacein-Bey-Abina, S.; Bartholomae, C. C.; Veres, G.; Schmidt, M.; Kutschera, I.; Vidaud, M.; Abel, U.; Dal-Cortivo, L.; Caccavelli, L.; Mahlaoui, N.; Kiermer, V.; Mittelstaedt, D.; Bellesme, C.; Lahlou, N.; Lefrere, F.; Blanche, S.; Audit, M.; Payen, E.; Leboulch, P.; l'Homme, B.; Bougneres, P.; von Kalle, C.; Fischer, A.; Cavazzana-Calvo, M.; Aubourg, P. (2009). "Hematopoietic Stem Cell Gene Therapy with a Lentiviral Vector in X-Linked Adrenoleukodystrophy". Science 326 (5954): 818. doi:10.1126/science.1171242. [7]
Baltimore, David; Berg, Paul; Botchan, Dana; Charo, R. Alta; Church, George; Corn, Jacob E.; Daley, George Q.; Doudna, Jennifer A.; Fenner, Marsha; Greely, Henry T.; Jinek, Martin; Martin, G. Steven; Penhoet, Edward; Puck, Jennifer; Sternberg, Samuel H.; Weissman, Jonathan S.; Yamamoto, Keith R. (19 March 2015). "A prudent path forward for genomic engineering and germline gene modification". Science. doi:10.1126/science.aab1028. Consultado o 20 March 2015.
Young, Susan (11 de febreiro de 2014) Genome SurgeryArquivado 15 de febreiro de 2014 en Wayback Machine. MIT Technology Review. Retrieved 17 February 2014
Pezzoli, D.; Chiesa, R.; De Nardo, L.; Candiani, G. (2012). " We still have a long way to go to effectively deliver genes!". Journal of Applied Biomaterials & Functional Materials 2 (10): 82. doi:10.5301/JABFM.2012.9707. [1]Arquivado 20 de xuño de 2015 en Wayback Machine.
"International Law". The Genetics and Public Policy Center, Johns Hopkins University Berman Institute of Bioethics. 2010. Arquivado dende o orixinal o 02 de setembro de 2014. Consultado o 08 de xuño de 2015.
2013, Human Cloning and Genetic Modification, Association of Reproductive Health Officials, [3]Arquivado 18 de xuño de 2013 en Wayback Machine.
"Gene Therapy". ama-assn.org. 4 April 2014. Arquivado dende o orixinal o 15 de marzo de 2015. Consultado o 22 March 2015.
Young, Susan (11 de febreiro de 2014) Genome SurgeryArquivado 15 de febreiro de 2014 en Wayback Machine. MIT Technology Review. Retrieved 17 February 2014
"The first gene therapy". Life Sciences Foundation. 21 June 2011. Arquivado dende o orixinal o 28 de novembro de 2012. Consultado o 7 January 2014.
B Williams-Jones. Somatic Cell Therapy: A Genetic Rescue for a Tattered Immune System? Bioétique online [6]Arquivado 19 de maio de 2014 en Wayback Machine.
Allhoff, F. (2005). "Germ-Line Genetic Enhancement and Rawlsian Primary Goods". Kennedy Institute of Ethics Journal 15: 39. doi:10.1353/ken.2005.0007. [11]Arquivado 21 de xuño de 2015 en Wayback Machine.